These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 37149826)

  • 21. Amyloid-β induced signaling by cellular prion protein and Fyn kinase in Alzheimer disease.
    Um JW; Strittmatter SM
    Prion; 2013; 7(1):37-41. PubMed ID: 22987042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease.
    Wu Y; Gong Y; Luan Y; Li Y; Liu J; Yue Z; Yuan B; Sun J; Xie C; Li L; Zhen J; Jin X; Zheng Y; Wang X; Xie L; Wang W
    FASEB J; 2020 Jan; 34(1):1412-1429. PubMed ID: 31914599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tyrosol Reduces Amyloid-β Oligomer Neurotoxicity and Alleviates Synaptic, Oxidative, and Cognitive Disturbances in Alzheimer's Disease Model Mice.
    Taniguchi K; Yamamoto F; Arai T; Yang J; Sakai Y; Itoh M; Mamada N; Sekiguchi M; Yamada D; Saitoh A; Kametani F; Tamaoka A; Araki YM; Wada K; Mizusawa H; Araki W
    J Alzheimers Dis; 2019; 70(3):937-952. PubMed ID: 31227651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synaptotoxic Signaling by Amyloid Beta Oligomers in Alzheimer's Disease Through Prion Protein and mGluR5.
    Brody AH; Strittmatter SM
    Adv Pharmacol; 2018; 82():293-323. PubMed ID: 29413525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MK-0677, a Ghrelin Agonist, Alleviates Amyloid Beta-Related Pathology in 5XFAD Mice, an Animal Model of Alzheimer's Disease.
    Jeong YO; Shin SJ; Park JY; Ku BK; Song JS; Kim JJ; Jeon SG; Lee SM; Moon M
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29912176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuronal transcriptome, tau and synapse loss in Alzheimer's knock-in mice require prion protein.
    Stoner A; Fu L; Nicholson L; Zheng C; Toyonaga T; Spurrier J; Laird W; Cai Z; Strittmatter SM
    Alzheimers Res Ther; 2023 Nov; 15(1):201. PubMed ID: 37968719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-PrP
    Cox TO; Gunther EC; Brody AH; Chiasseu MT; Stoner A; Smith LM; Haas LT; Hammersley J; Rees G; Dosanjh B; Groves M; Gardener M; Dobson C; Vaughan T; Chessell I; Billinton A; Strittmatter SM
    Ann Clin Transl Neurol; 2019 Mar; 6(3):554-574. PubMed ID: 30911579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prions and Neurodegenerative Diseases: A Focus on Alzheimer's Disease.
    Crestini A; Santilli F; Martellucci S; Carbone E; Sorice M; Piscopo P; Mattei V
    J Alzheimers Dis; 2022; 85(2):503-518. PubMed ID: 34864675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
    DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
    Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Domains of STIP1 responsible for regulating PrPC-dependent amyloid-β oligomer toxicity.
    Maciejewski A; Ostapchenko VG; Beraldo FH; Prado VF; Prado MA; Choy WY
    Biochem J; 2016 Jul; 473(14):2119-30. PubMed ID: 27208175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.
    Devi L; Ohno M
    Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rescue of Transgenic Alzheimer's Pathophysiology by Polymeric Cellular Prion Protein Antagonists.
    Gunther EC; Smith LM; Kostylev MA; Cox TO; Kaufman AC; Lee S; Folta-Stogniew E; Maynard GD; Um JW; Stagi M; Heiss JK; Stoner A; Noble GP; Takahashi H; Haas LT; Schneekloth JS; Merkel J; Teran C; Naderi ZK; Supattapone S; Strittmatter SM
    Cell Rep; 2019 Jan; 26(1):145-158.e8. PubMed ID: 30605671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alzheimer's Aβ interacts with cellular prion protein inducing neuronal membrane damage and synaptotoxicity.
    Peters C; Espinoza MP; Gallegos S; Opazo C; Aguayo LG
    Neurobiol Aging; 2015 Mar; 36(3):1369-77. PubMed ID: 25599875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Memory impairment in transgenic Alzheimer mice requires cellular prion protein.
    Gimbel DA; Nygaard HB; Coffey EE; Gunther EC; Laurén J; Gimbel ZA; Strittmatter SM
    J Neurosci; 2010 May; 30(18):6367-74. PubMed ID: 20445063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current Research Therapeutic Strategies for Alzheimer's Disease Treatment.
    Folch J; Petrov D; Ettcheto M; Abad S; Sánchez-López E; García ML; Olloquequi J; Beas-Zarate C; Auladell C; Camins A
    Neural Plast; 2016; 2016():8501693. PubMed ID: 26881137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accumulation of cellular prion protein within β-amyloid oligomer plaques in aged human brains.
    Takahashi RH; Yokotsuka M; Tobiume M; Sato Y; Hasegawa H; Nagao T; Gouras GK
    Brain Pathol; 2021 Sep; 31(5):e12941. PubMed ID: 33624334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adiponectin suppresses amyloid-β oligomer (AβO)-induced inflammatory response of microglia via AdipoR1-AMPK-NF-κB signaling pathway.
    Jian M; Kwan JS; Bunting M; Ng RC; Chan KH
    J Neuroinflammation; 2019 May; 16(1):110. PubMed ID: 31128596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dopamine analogue CA140 alleviates AD pathology, neuroinflammation, and rescues synaptic/cognitive functions by modulating DRD1 signaling or directly binding to Abeta.
    Chae S; Lee HJ; Lee HE; Kim J; Jeong YJ; Lin Y; Kim HY; Leriche G; Ehrlich RS; Lingl SC; Seo MD; Lee YH; Yang J; Kim JI; Hoe HS
    J Neuroinflammation; 2024 Aug; 21(1):200. PubMed ID: 39129007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liquid and Hydrogel Phases of PrP
    Kostylev MA; Tuttle MD; Lee S; Klein LE; Takahashi H; Cox TO; Gunther EC; Zilm KW; Strittmatter SM
    Mol Cell; 2018 Nov; 72(3):426-443.e12. PubMed ID: 30401430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of mGluR5/PI3K-AKT Pathway Alleviates Alzheimer's Disease-Like Pathology Through the Activation of Autophagy in 5XFAD Mice.
    Chen Y; Zhang Y; Chen Q; Liu Y; Wei X; Wu M; Zhang K; Liu Y; Wei W
    J Alzheimers Dis; 2023; 91(3):1197-1214. PubMed ID: 36565127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.